Abstract:The recent wide spreading of the H5N1 avian influenza virus (AIV) in Asia, Europe and Africa and its ability to cause fatal infections in human has raised serious concerns about a pending global flu pandemic. Neuraminidase (NA) inhibitors are currently the only option for treatment or prophylaxis in humans infected with this strain. However, drugs currently on the market often meet with rapidly emerging resistant mutants and only have limited application as inadequate supply of synthetic material. To dig out helpful information for designing potent inhibitors with novel structures against the NA, we used automated docking, CoMFA, CoMSIA, and HQSAR methods to investigate the quantitative structure–activity relationship for 126 NA inhibitors (NIs) with great structural diversities and wide range of bioactivities against influenza A virus. Based on the binding conformations discovered via molecular docking into the crystal structure of NA, CoMFA and CoMSIA models were successfully built with the cross-validated q 2 of 0.813 and 0.771, respectively. HQSAR was also carried out as a complementary study in that HQSAR technique does not require 3D information of these compounds and could provide a detailed molecular fragment contribution to the inhibitory activity. These models also show clearly how steric, electrostatic, hydrophobicity, and individual fragments affect the potency of NA inhibitors. In addition, CoMFA and CoMSIA field distributions are found to be in well agreement with the structural characteristics of the corresponding binding sites. Therefore, the final 3D-QSAR models and the information of the inhibitor–enzyme interaction should be useful in developing novel potent NA inhibitors.

Chemical Structural Characterization And Design Of Influenza Neuraminidase Inhibitors Using Three-Dimensional Holographicvector Of Atomic Interaction Field Through Quantitative Structure-Activity Relationship Studies

QSAR studies on influenza neuraminidase inhibitors of cyclohexenes

On Three‐Dimensional Holographic Vector of Atomic Interaction Field Analysis for Influenza Neuraminidase Inhibitors

Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis.

Three Dimensional Quantitative Structure-activity Relationship of Cyclohexene Neuraminidase Inhibitors

Qsar and Pharmacophore Studies of Thiazolidine-4-Carboxylic Acid Derivatives As Novel Influenza Neuraminidase Inhibitors Using Hqsar, Topomer Comfa and Comsia

2D-QSAR Study of Carbocyclic Derivates Neuraminidase Inhibitors

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico.

Pharmacophore Modeling, 3D‐QSAR Studies, and In‐silico ADME Prediction of Pyrrolidine Derivatives As Neuraminidase Inhibitors

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico

QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network

Study on Quantitative Structure-Activity Relationship by 3d Holographic Vector of Atomic Interaction Field

Docking and 3D QSAR Study of Thiourea Analogs As Potent Inhibitors of Influenza Virus Neuraminidase.

In Vitro Anti-Viral Activities and Structure-Activity Relationship Studies of Flavones and Dihydroflavone Derivatives As Influenza Virus Potential Neuraminidase Inhibitors

Quantitative Structure Activity Relationship Studies of Anti-Tuberculosis Drug Using Three-Dimensional Structure Descriptors

Molecular Docking, 3d-Qsar Studies, And In Silico Adme Prediction Of P-Aminosalicylic Acid Derivatives As Neuraminidase Inhibitors

QSAR Study on Some N-[5-（2-Furanyl）-2-methyl-4-oxo-4H-thieno[2,3-d]pyrimidin-3-yl]-carboxamide and 3-Substituted-5-（2-furanyl）-2-methyl-3h-thieno-[2,3-d]pyrimidin-4-ones Using Three-dimensional Holographic Vector of Atomic Interaction Field

Discovery of Neuraminidase Inhibitors based on 3D-QSAR, Molecular Docking and MD Simulations

Quantitative Structure_Activity Relationship Studies of Nevirapine Derivatives Anti-HIV Drug using New Three-dimensional Structure Descriptors

QSAR studies of HETP anti-HIV drug using three-dimensional holographic vector of atomic interaction field (3D-HoVAIF)

QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR